“This groundbreaking FDA medical device designation sets a new standard in the healthcare apparel market and addresses a major unmet need for healthcare worker safety,” said Bill Bold, CEO of Vestagen.
Vestex apparel is designed to protect healthcare workers from exposure to microorganisms from blood, body fluids and other potentially infectious material.
The FDA cleared Vestex scrub tops, pants, skirts and lab coats to reduce the retention of Methicillin-resistant Staphylococcus aureus on the outer layer of the apparel.
The fluid-repellent fabric surface serves to resist bacteria by repelling fluids and reducing microorganisms remaining on the fabric. The antimicrobial agent then further reduces the MRSA that remains on the surface (outer layer) of the apparel.
The apparel’s ability to reduce the retention of MRSA on the fabric surface has not been shown to correlate with the reduction of infections.
More articles on clinical leadership infection control:
Obese hospital patients less likely to die from sepsis, study finds
Viewpoint: Why state-mandated nurse ratios could harm patient safety
Missouri heart attack patients now sent to best-equipped hospital — not always the closest
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
